The burgeoning digital marketplace has presented novel avenues for accessing prescription drugs, including the stimulant Adderall, primarily recommended for attention deficit hyperactivity disorder (ADHD). While advocates of cognitive enhancement argue that these substances can improve focus and productivity, ethical concerns surge surrounding the